In a filing, Resmed Inc revealed its Chief Executive Officer Farrell Michael J. unloaded Company’s shares for reported $2.06 million on Jul 07 ’25. In the deal valued at $256.72 per share,8,009 shares were sold. As a result of this transaction, Farrell Michael J. now holds 455,503 shares worth roughly $117.48 million.
Then, Farrell Michael J. bought 8,009 shares, generating $2,056,076 in total proceeds.
Before that, FARRELL PETER C sold 945 shares. Resmed Inc shares valued at $241,438 were divested by the Director at a price of $255.49 per share. As a result of the transaction, FARRELL PETER C now holds 68,273 shares, worth roughly $17.61 million.
RBC Capital Mkts upgraded its Resmed Inc [RMD] rating to an Outperform from a a Sector perform in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. Morgan Stanley began covering RMD with “an Overweight” recommendation on March 19, 2025. Goldman started covering the stock on January 16, 2025. It rated RMD as “a Buy”.
Price Performance Review of RMD
On Friday, Resmed Inc [NYSE:RMD] saw its stock jump 0.58% to $257.92. Over the last five days, the stock has gained 1.38%. Resmed Inc shares have risen nearly 24.72% since the year began. Nevertheless, the stocks have risen 12.78% over the past one year. While a 52-week high of $263.05 was reached on 01/30/25, a 52-week low of $196.43 was recorded on 04/07/25.
Levels Of Support And Resistance For RMD Stock
The 24-hour chart illustrates a support level at 256.18, which if violated will result in even more drops to 254.43. On the upside, there is a resistance level at 260.02. A further resistance level may holdings at 262.11.
How much short interest is there in Resmed Inc?
A steep rise in short interest was recorded in Resmed Inc stocks on 2025-06-13, dropping by -1.01 million shares to a total of 9.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 10.93 million shares. There was a decline of -10.12%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 10, 2025 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating along with a $252 price target.
